282 related articles for article (PubMed ID: 23582787)
1. Enhanced tumorigenesis and lymphatic metastasis of CD133+ hepatocarcinoma ascites syngeneic cell lines mediated by JNK signaling pathway in vitro and in vivo.
Jin Y; Mao J; Wang H; Hou Z; Ma W; Zhang J; Wang B; Huang Y; Zang S; Tang J; Li L
Biomed Pharmacother; 2013 May; 67(4):337-45. PubMed ID: 23582787
[TBL] [Abstract][Full Text] [Related]
2. Ezrin expression is altered in mice lymphatic metastatic hepatocellular carcinoma and subcellular fractions upon Annexin 7 modulation in-vitro.
Hago AM; Gamallat Y; Mahmoud SA; Huang Y; Zhang J; Mahmoud YK; Wang J; Wei Y; Wang L; Zhou S; Awsh MA; Yabasin IB; Tang J
Biomed Pharmacother; 2017 Jan; 85():209-217. PubMed ID: 27914826
[TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotide-binding protein subunit beta-2-like 1, a new Annexin A7 interacting protein.
Du Y; Meng J; Huang Y; Wu J; Wang B; Ibrahim MM; Tang J
Biochem Biophys Res Commun; 2014 Feb; 445(1):58-63. PubMed ID: 24491534
[TBL] [Abstract][Full Text] [Related]
4. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
[TBL] [Abstract][Full Text] [Related]
5. RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway.
Wu J; Meng J; Du Y; Huang Y; Jin Y; Zhang J; Wang B; Zhang Y; Sun M; Tang J
Biomed Pharmacother; 2013 May; 67(4):313-9. PubMed ID: 23582786
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms.
Wang XY; Gao F; Sun YR; Bai LL; Ibrahim MM; Wang B; Tang JW
Tumour Biol; 2016 Jan; 37(1):911-24. PubMed ID: 26256045
[TBL] [Abstract][Full Text] [Related]
7. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
8. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
9. Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability.
Zhou H; Jia L; Wang S; Wang H; Chu H; Hu Y; Cao J; Zhang J
Biochem Biophys Res Commun; 2006 Jun; 345(1):486-94. PubMed ID: 16684506
[TBL] [Abstract][Full Text] [Related]
10. ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma.
Tong M; Fung TM; Luk ST; Ng KY; Lee TK; Lin CH; Yam JW; Chan KW; Ng F; Zheng BJ; Yuan YF; Xie D; Lo CM; Man K; Guan XY; Ma S
Stem Cell Reports; 2015 Jul; 5(1):45-59. PubMed ID: 26095609
[TBL] [Abstract][Full Text] [Related]
11. Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun(Ser73) and E-cadherin.
Sun X; Wei B; Liu S; Guo C; Wu N; Liu Q; Sun MZ
Biomed Pharmacother; 2016 Dec; 84():645-654. PubMed ID: 27697636
[TBL] [Abstract][Full Text] [Related]
12. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
[TBL] [Abstract][Full Text] [Related]
13. Subcellular proteomics: determination of specific location and expression levels of lymphatic metastasis associated proteins in hepatocellular carcinoma by subcellular fractionation.
Qazi AS; Sun M; Huang Y; Wei Y; Tang J
Biomed Pharmacother; 2011 Sep; 65(6):407-16. PubMed ID: 21741201
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
15. CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy.
Li J; Chen JN; Zeng TT; He F; Chen SP; Ma S; Bi J; Zhu XF; Guan XY
BMC Cancer; 2016 Jan; 16():15. PubMed ID: 26758620
[TBL] [Abstract][Full Text] [Related]
16. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
[TBL] [Abstract][Full Text] [Related]
17. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.
Yang Z; Zhang L; Ma A; Liu L; Li J; Gu J; Liu Y
PLoS One; 2011; 6(12):e28405. PubMed ID: 22145042
[TBL] [Abstract][Full Text] [Related]
18. Annexin A7 gene is an important factor in the lymphatic metastasis of tumors.
Jin YL; Wang ZQ; Qu H; Wang HX; Ibrahim MM; Zhang J; Huang YH; Wu J; Bai LL; Wang XY; Meng JY; Tang JW
Biomed Pharmacother; 2013 May; 67(4):251-9. PubMed ID: 23540285
[TBL] [Abstract][Full Text] [Related]
19. ANXA11 regulates the tumorigenesis, lymph node metastasis and 5-fluorouracil sensitivity of murine hepatocarcinoma Hca-P cells by targeting c-Jun.
Liu S; Guo C; Wang J; Wang B; Qi H; Sun MZ
Oncotarget; 2016 Mar; 7(13):16297-310. PubMed ID: 26908448
[TBL] [Abstract][Full Text] [Related]
20. Annexin A7 and its binding protein galectin-3 influence mouse hepatocellular carcinoma cell line in vitro.
Song L; Mao J; Zhang J; Ibrahim MM; Li LH; Tang JW
Biomed Pharmacother; 2014 Apr; 68(3):377-84. PubMed ID: 24373698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
